There's a new player on the antibody-drug conjugate (ADC) scene. UK-based Pheon Therapeutics has entered stage right with $68 million in funding that will be used to fund development of a pipeline of ...

The logo of Google is seen in Davos, Switzerland Januar 20, 2020. REUTERS/Arnd Wiegmann/File Photo Alphabet's Google on Friday failed to persuade a U.S. appeals court to further freeze an order ...

PARIS — Results from the REMAIN long-term follow-up study on MCO-010, an optogenetic therapy for retinitis pigmentosa, showed durable efficacy over 3 years.

Everyday Health’s team of board-certified physicians and health professionals contribute to the creation and review of content, ensuring that the information is useful, up to date, and accurate. Susan ...